Skip to main content

POET Technologies Inc. (POET) Stock Forecast

Data as of Jul 31, 2026

Technology · Current price $7.05 (-3.16%)

Consensus Target
$5.75
Upside
-17.1%
Analysts
Rating

Price Target Range

Low $3.50Consensus $5.75High $8.00
▲ Current $7.05

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

No ratings in the last 3 months.
Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0

6-Month Trend

No rating trend data.

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
Sep 12, 2024Richard ShannonCraig-Hallum$3.50-50.4%

POET vs Sector & Market

MetricPOETTechnology AvgLarge Cap Avg
Analyst Rating2.362.42
Analyst Count1419
Target Upside-17.1%+1711.0%+18.0%
P/E Ratio-11.8837.7043.33

Revenue Estimates

PeriodLowAvgHigh#
2026-09-30$2M$2M$2M1
2026-12-30$13M$13M$13M1
2026-12-31$6M$6M$6M1
2027-12-31$80M$80M$80M1

EPS Estimates

PeriodLowAvgHigh#
2026-09-30$-0.04$-0.04$-0.041
2026-12-30$0.02$0.02$0.021
2026-12-31$-0.03$-0.03$-0.031
2027-12-31$0.05$0.05$0.051

Frequently Asked Questions

What is the analyst consensus for POET?

The consensus among 0 analysts covering POET Technologies Inc. (POET) is — with an average price target of $5.75.

What is the highest price target for POET?

The highest price target for POET is $3.50, set by Richard Shannon at Craig-Hallum on 2024-09-12.

What is the lowest price target for POET?

The lowest price target for POET is $3.50, set by Richard Shannon at Craig-Hallum on 2024-09-12.

How many analysts cover POET?

0 analysts have issued ratings for POET Technologies Inc. in the past 12 months.

Is POET a buy or sell right now?

Based on 0 analyst ratings, POET has a consensus rating of — with a -17.1% upside to the consensus target of $5.75.

What are the earnings estimates for POET?

Analysts estimate POET will report EPS of $-0.04 for the period ending 2026-09-30, with revenue estimated at $2M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.